958253-50-4

Upstream product

• 1005175-45-0 N-(2-methylphenyl)-3-bromo-4,6-dibenzyloxybenzamide hydrazone 
• 530-62-1 1,1'-carbonyldiimidazole 

Downstream Products

• 958251-18-8 5-[2,4-dihydroxy-5-(N-benzyl-N-methylaminocarbonyl)phenyl]-4-(2-methylphenyl)-3-hydroxy-4H-1,2,4-triazole 
• 1222378-80-4 C₃₁H₂₈N₄O₄ 
• 1222377-15-2 C₃₈H₃₄N₄O₄ 
• 1005175-46-1 C₂₄H₂₁N₃O₅ 
• 1005175-47-2 C₃₁H₂₇N₃O₅ 
• 1005175-49-4 C₂₃H₁₉N₃O₅ 
• 1005175-48-3 C₃₀H₂₅N₃O₅ 
• 1041201-90-4 5-[4-(2-methylphenyl)-3-hydroxy-4H-1,2,4-triazol-5-yl]-2,4-bisbenzyloxy-N-methyl-N-butylbenzamide 

Relevant academic research and scientific papers

TRIAZOLE DERIVATIVE AS AN HSP 90 INHIBITOR

5-[4-(2-Methylphenyl)-3-hydroxy-4H-1,2,4-triazol-5-yl]-2,4-dihydroxy-N-methyl-N-butylbenzamide is an HSP90 inhibitor and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.

TRIAZOLE DERIVATIVES II

Novel triazole derivatives of the formula (I) in which R1—R6 and Y have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.